Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Dec 22;358(24):4085-4092.
doi: 10.1002/adsc.201601089. Epub 2016 Dec 8.

Total Synthesis of Viniferifuran, Resveratrol-Piceatannol Hybrid, Anigopreissin A and Analogues - Investigation of Demethylation Strategies

Affiliations

Total Synthesis of Viniferifuran, Resveratrol-Piceatannol Hybrid, Anigopreissin A and Analogues - Investigation of Demethylation Strategies

Duc Duy Vo et al. Adv Synth Catal. .

Abstract

Resveratrol-based natural products constitute a valuable source of unique compounds with diverse biological activities. In this report we investigate demethylation strategies to minimize formation of cyclized and dimerized products during the synthesis of viniferifuran and analogues. We found that boron trichloride/tetra-n-butylammonium iodide (BCl3/TBAI) is typically more effective than boron tribromide (BBr3). Based on these findings we carried out the first syntheses of dehydro-δ-viniferin, resveratrol-piceatannol hybrid and anigopreissin A. In addition, we have developed a short and efficient route to viniferifuran that was obtained in 13% yield over six steps.

Keywords: demethylation; natural products; polyphenols; resveratrol oligomers; stilbenoids; total synthesis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Selected natural and non‐natural resveratrol dimers and the stilbenoid diptoindonesin G.
Scheme 1
Scheme 1
Modified synthetic route to viniferifuran. Reagents and conditions: a) LiAlH4 (3 equiv.), THF, 0 °C, 10 min. b) Dess–Martin periodinane (1.2 equiv.), DCM, 0 °C, 1 h, 80–90%, 2 steps. c) ArBr or ArI (1.5–2 equiv.), Pd(OAc)2 (0.1 equiv.), PCy3⋅HBF4 (0.2 equiv.), K2CO3 (1.5 equiv.), PivOH (3 equiv.), 100 °C, 20 h, 74%. d) ArBr (1.5–2 equiv.), PdCl(C3H5)dppb (0.05 equiv.), KOAc (2 equiv.), DMA, 150 °C, 20 h, 60%. e) Phosphonate derivatives (1.5 equiv.), NaH (3 equiv.), THF, 120 °C, MWI, 30 min, 80%. f) BCl3, TBAI, DCM, 0 °C to room temperature, 6 h, 23% (HPLC).
Scheme 2
Scheme 2
Modified synthetic route to viniferifuran. Reagents and conditions: a) ArBr or ArI (1.5–2 equiv.), Pd(OAc)2 (0.1 equiv.), PCy3⋅HBF4 (0.2 equiv.), K2CO3 (1.5 equiv.), PivOH (3 equiv.), 100 °C, 20 h, 35–74%. b) ArBr (1.5–2 equiv.), PdCl(C3H5)(dppb) (0.05 equiv.), KOAc (2 equiv.), DMA, 150 °C, 20 h, 47–60%. c) Phosphonate derivatives (1.5 equiv.), NaH (3 equiv.), THF, 120 °C, MWI, 30 min, 52–82%. d) BCl3, TBAI, DCM, 0 °C to room temperature, 6 h.
Scheme 3
Scheme 3
Alternative routes for the synthesis of viniferifuran and analogues. Reagents and conditions: a) Phosphonate derivatives (1.5 equiv.), NaH (3 equiv.), THF, 120 °C, MWI, 30 min, 60–80%. b) BBr3 (9–12 equiv.), DCM, −78 °C to room temperature, 6 h. c) Ac2O, THF, Et3N, room temperature, overnight, 38–62%, 2 steps. d) NBS (3 equiv.), pTsOH, room temperature, 24–48 h. e) KOH, MeOH, 0 °C, 30 min, 15–30%, 2 steps. f) PdCl2(dppf)⋅DCM (5% mol), boronic acid (1.5–2 equiv.), Na2CO3, DME/H2O (1/1), 70 °C, MWI, 30 min, 41–76%. g) 4‐Bromoanisole (2 equiv.), Pd(OAc)2 (0.1 equiv.), PCy3⋅HBF4 (0.2 equiv.), K2CO3 (1.5 equiv.), PivOH (3 equiv.), 100 °C, 20 h, 25–36%. h) Styrene derivatives (1.2 equiv.), Pd(OAc)2 (0.1 equiv.), dppp (0.1 equiv.), Et3N, DMF, 120 °C, 20 h, 25–64%.
Scheme 4
Scheme 4
Total synthesis of anigopreissin A, resveratrol‐piceatannol hybrid and dehydro‐δ‐viniferin. Reagents and conditions: a) PdCl2(PPh3)2 (5% mol), CuI (3% mol), ethynylanisole (1.2–1.5 equiv.), Et3N/THF (2/1), MWI, 40 °C, 30 min then CH3CN, 100 °C, MWI, 30 min, 74–90%. b) MeI, K2CO3, DMF, room temperature, overnight, 77%. c) NIS (1 equiv.), pTsOH cat., CH3CN, room temperature, overnight, 59%. d) PdCl2(dppf)⋅DCM (5% mol), 3,5‐dimethoxyphenylboronic acid (1.5 equiv.), K2CO3, DME/H2O (4/1), 80–100 °C, MWI, 30 min, 83–91%. e) Phosphonate derivatives (1.5 equiv.), NaH (3 equiv.), THF, 120 °C, MWI, 30 min, 58–84%. f) BBr3, DCM, −78 °C to room temperature, 6 h. g) BCl3, TBAI, DCM, 0 °C to room temperature, 6 h. h) NBS (1.1 equiv.), DCM, room temperature, overnight, 50%. i) PdCl2(PPh3)2 (5% mol), CuI (3% mol), 4‐ethynylanisole (1.2–1.5 equiv.), Et3N/THF (2/1), MWI, 40 °C, 30 min then 1‐iodo‐3,5‐dimethoxybenzene (1.5 equiv.), CH3CN, 100 °C, MWI, 30 min, 25% 33+60% 32. j) 1‐Bromo‐3,5‐dimethoxybenzene (1.5 equiv.), PdCl(C3H5)dppb (5% mol), KOAc (2 equiv.), DMA, 150 °C, 20 h, 60%.

Similar articles

Cited by

References

    1. None
    1. Shen T., Wang X.-N., Lou H.-X., Nat. Prod. Rep. 2009, 26, 916; - PubMed
    1. Quideau S., Deffieux D., Douart-Cassassus C., Pouysegu L., Angew. Chem. 2011, 123, 610;
    2. Angew. Chem. Int. Ed. 2011, 50, 586; - PubMed
    1. Riviere C., Pawlus A. D., Merillon J.-M., Nat. Prod. Rep. 2012, 29, 1317; - PubMed
    1. Keylor M. H., Matsuura B. S., Stephenson C. R. J., Chem. Rev. 2015, 115, 8976. - PMC - PubMed